Received Mar 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
Caller states a 27 year old patient missed their second dose. The first dose was administered on 11/07/2024 and they have not received their second dose as of yet.; No other AE; This spontaneous report was received from a pharmacist and refers to a 27-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 07-NOV-2024, the patient was vaccinated with the first dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) administered as prophylaxis (Lot No., expiration date, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided) It was reported that the patient did not received he second dose of the previous mention vaccine as of yet (Inappropriate schedule of product administration). No other adverse event (No adverse event).